Efficacy and safety of nanoliposomal irinotecan plus fluorouracil and folinic acid after irinotecan-based chemotherapy in patients with advanced pancreatic cancer: Results of the retrospective part of the NAPOLEON-2 study.

被引：0
|
作者：
Kawaguchi, Yasunori
Aikawa, Tomomi
Shimokawa, Mototsugu
Otsuka, Taiga
Shibuki, Taro
Nakazawa, Junichi
Arima, Shiho
Miwa, Keisuke
Koga, Futa
Ueda, Yujiro
Kubotsu, Yoshihito
Shimokawa, Hozumi
Takeshita, Shigeyuki
Nishikawa, Kazuo
Hosokawa, Ayumu
Oda, Hisanobu
Sakai, Tatsunori
Shirakawa, Tsuyoshi
Mizuta, Toshihiko
Mitsugi, Kenji
机构：
[1] Asakura Med Assoc Hosp, Asakura, Japan
[2] Japan Community Healthcare Org Kyushu Hosp, Kitakyushu, Fukuoka, Japan
[3] Yamaguchi Univ, Grad Sch Med, Dept Biostat, Yamaguchi, Japan
[4] Minato Med Clin, Fukuoka, Japan
[5] Natl Canc Ctr Hosp East, Kashiwa, Chiba, Japan
[6] Kagoshima City Hosp, Kagoshima, Japan
[7] Kagoshima Univ, Grad Sch Med & Dent Sci, Kagoshima, Japan
[8] Kurume Univ Hosp, Kurume, Fukuoka, Japan
[9] Saga Med Ctr Koseikan, Saga, Japan
[10] Japanese Red Cross Kumamoto Hosp, Kumamoto, Japan
[11] Karatsu Red Cross Hosp, Karatsu, Japan
[12] Japanese Red Cross Nagasaki Genbaku Hosp, Nagasaki, Japan
[13] Oita Univ, Fac Med, Yufu, Japan
[14] Univ Miyazaki Hosp, Dept Clin Oncol, Miyazaki, Japan
[15] Saiseikai Kumamoto Hosp, Kumamoto, Japan
[16] Natl Hosp Org Kumamoto Med Ctr, Kumamoto, Japan
[17] Karatsu Higashimatsuura Med Assoc Ctr, Karatsu, Japan
[18] Fujikawa Hosp, Saga, Japan
[19] Sasebo Kyosai Hosp, Sasebo, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
705
引用
收藏
页码：705 / 705
页数：1
相关论文
共 50 条
  • [31] Real-world efficacy and safety of liposomal irinotecan plus fluorouracil/leucovorin in patients with metastatic pancreatic adenocarcinoma: a study by the Korean Cancer Study Group
    Yoo, Changhoon
    Im, Hyeon-Su
    Kim, Kyu-pyo
    Oh, Do-Youn
    Lee, Kyung-Hun
    Chon, Hong Jae
    Kim, Joo Hoon
    Kang, Myoungjoo
    Kim, Ilhwan
    Lee, Guk Jin
    Oh, Sung Yong
    Choi, Younak
    Choi, Hye Jin
    Kim, Seung Tae
    Park, Joon Oh
    Ryoo, Baek-Yeol
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2019, 11
  • [32] Irinotecan plus S-1 (IRIS) versus fluorouracil and folinic acid plus irinotecan (FOLFIRI) as second-line chemotherapy for metastatic colorectal cancer: a randomised phase 2/3 non-inferiority study (FIRIS study)
    Muro, Kei
    Boku, Narikazu
    Shimada, Yasuhiro
    Tsuji, Akihito
    Sameshima, Shinichi
    Baba, Hideo
    Satoh, Taroh
    Denda, Tadamichi
    Ina, Kenji
    Nishina, Tomohiro
    Yamaguchi, Kensei
    Takiuchi, Hiroya
    Esaki, Taito
    Tokunaga, Shinya
    Kuwano, Hiroyuki
    Komatsu, Yoshito
    Watanabe, Masahiko
    Hyodo, Ichinosuke
    Morita, Satoshi
    Sugihara, Kenichi
    LANCET ONCOLOGY, 2010, 11 (09): : 853 - 860
  • [33] Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial
    Wang-Gillam, Andrea
    Li, Chung-Pin
    Bodoky, Gyoergy
    Dean, Andrew
    Shan, Yan-Shen
    Jameson, Gayle
    Macarulla, Teresa
    Lee, Kyung-Hun
    Cunningham, David
    Blanc, Jean F.
    Hubner, Richard A.
    Chiu, Chang-Fang
    Schwartsmann, Gilberto
    Siveke, Jens T.
    Braiteh, Fadi
    Moyo, Victor
    Belanger, Bruce
    Dhindsa, Navreet
    Bayever, Eliel
    Von Hoff, Daniel D.
    Chen, Li-Tzong
    LANCET, 2016, 387 (10018): : 545 - 557
  • [34] A phase I/II study of nanoliposomal irinotecan plus S-1 in metastatic pancreatic cancer after first-line gemcitabine-based chemotherapy
    Imaoka, H.
    Sasaki, M.
    Ueno, M.
    Ozaka, M.
    Kobayashi, S.
    Fukushima, T.
    Furukawa, T.
    Ikeda, M.
    ANNALS OF ONCOLOGY, 2022, 33 : S1484 - S1484
  • [35] Irinotecan, oxaliplatin plus bolus 5-fluorouracil and low dose folinic acid every 2 weeks - A feasibility study in metastatic colorectol cancer patients
    Martinez, J
    Martin, C
    Chacon, M
    Korbenfeld, E
    Bella, S
    Senna, S
    Richardet, E
    Coppola, F
    Bas, C
    Hidalgo, J
    Escobar, E
    Reale, M
    Smilovich, AM
    Wasserman, E
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2006, 29 (01): : 45 - 51
  • [36] Liposomal irinotecan plus fluorouracil/leucovorin versus FOLFIRINOX as the second-line chemotherapy for patients with metastatic pancreatic cancer: a multicenter retrospective study of the Korean Cancer Study Group (KCSG)
    Park, H. S.
    Kang, B.
    Chon, H. J.
    Im, H-S
    Lee, C-K
    Kim, I
    Kang, M. J.
    Hwang, J. E.
    Bae, W. K.
    Cheon, J.
    Park, J. O.
    Hong, J. Y.
    Kang, J. H.
    Kim, J. H.
    Lim, S. H.
    Kim, J. W.
    Kim, J-W
    Yoo, C.
    Choi, H. J.
    ESMO OPEN, 2021, 6 (02)
  • [37] SAFETY AND EFFICACY OF IMPRIME PGG PLUS CETUXIMAB WITH IRINOTECAN AND WITHOUT IRINOTECAN IN PATIENTS WITH ADVANCED COLORECTAL CANCER (CRC): A PHASE 1B/2 STUDY WITH KRAS SUBPOPULATION ANALYSIS
    Tamayo, M.
    Cornelio, G.
    Bautista, J.
    Flores, M.
    Tioleco, P.
    Kurman, M.
    Vasilakos, J.
    Marsh, L.
    Gargano, M.
    Patchen, M.
    ANNALS OF ONCOLOGY, 2010, 21 : 22 - 23
  • [38] Final results of the randomized phase II study of sequential docetaxel and irinotecan with infusion 5-fluorouracil/folinic acid in patients with advanced gastric cancer - GA-TAC
    Lind, P. A.
    Gubanski, M.
    Johnsson, A.
    Fernebro, E.
    Flygare, P.
    Karlberg, I.
    Kadar, L.
    Glimelius, B.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [39] Analysis of UGT1A1*28 genotype and SN-38 pharmacokinetics for irinotecan-based chemotherapy in patients with advanced colorectal cancer: results from a multicenter, retrospective study in Shanghai
    Cai, Xun
    Cao, Weiguo
    Ding, Honghua
    Liu, Tianshu
    Zhou, Xinli
    Wang, Mei
    Zhong, Ming
    Zhao, Ziyi
    Xu, Qing
    Wang, Liwei
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2013, 139 (09) : 1579 - 1589
  • [40] Analysis of UGT1A1*28 genotype and SN-38 pharmacokinetics for irinotecan-based chemotherapy in patients with advanced colorectal cancer: results from a multicenter, retrospective study in Shanghai
    Xun Cai
    Weiguo Cao
    Honghua Ding
    Tianshu Liu
    Xinli Zhou
    Mei Wang
    Ming Zhong
    Ziyi Zhao
    Qing Xu
    Liwei Wang
    Journal of Cancer Research and Clinical Oncology, 2013, 139 : 1579 - 1589
12345